Company profile: Astrin Biosciences
1.1 - Company Overview
Company description
- Provider of an AI-empowered 3D holographic imaging platform that uses deep learning to analyze individual cells for early cancer detection and treatment management; a biotechnology research center for 3D holographic images and learning.
Products and services
- AI-Empowered 3D Holographic Imaging Platform: Utilizes AI and 3D holographic imaging to analyze individual cells for early cancer detection and treatment management, platform-scale
- Biotechnology Research in 3D Holographic Imaging and Learning: Conducts laboratory-grade investigations on 3D holographic images and AI learning for single-cell analysis aiding early cancer detection and treatment management
- Deep Learning–Based Single-Cell Analysis: Applies deep learning with 3D holographic imaging to interrogate individual cells for early cancer detection and treatment management
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Astrin Biosciences
i-Human Patients
HQ: United States
Website
- Description: Provider of cloud-based, interactive medical education simulation solutions, including the i-Human Patients platform for virtual patient encounters and structured clinical cases across medical, physician assistant, and nursing programs (graduate and undergraduate), with over 350 cases and 230 avatars, Next Generation NCLEX-aligned cases, and OSCEs (12 cases) for formative learning and competency assessment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full i-Human Patients company profile →
Global Imaging Online
HQ: France
Website
- Description: Provider of medical imaging solutions to patients, developed through collaboration between development engineers and doctors with long experience in medical imaging and computing. Based in France in the Paris area.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Global Imaging Online company profile →
Online Business Applications
HQ: United States
Website
- Description: Provider of software solutions for medical information departments, delivering appropriate, cost-effective systems based on a comprehensive understanding of their unique requirements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Online Business Applications company profile →
MD Revolution
HQ: United States
Website
- Description: Provider of technology, services, and analytics to produce scalable, high touch care models. Offers the RevUp Care Management Platform integrating with EHRs, medical devices, and health apps to facilitate patient engagement and care coordination, plus RPM, Chronic Care Management (including Medicare CCM), Behavioral Health Integration, Annual Wellness Visits, and Transitional Care Management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MD Revolution company profile →
Data Sciences International
HQ: United States
Website
- Description: Provider of physiologic monitoring solutions for biomedical research in systems physiology and pharmacology. The recognized global leader, offering implantable and jacketed external telemetry; Ponemah, NeuroScore, and FinePointe software for multi-signal acquisition and analysis; and Buxco respiratory systems. Serves pharmaceuticals, academia, and CROs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Data Sciences International company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Astrin Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Astrin Biosciences
2.2 - Growth funds investing in similar companies to Astrin Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Astrin Biosciences
4.2 - Public trading comparable groups for Astrin Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →